TEKANOL

This brand name is authorized in Nigeria.

Active ingredients

The drug TEKANOL contains a combination of these active pharmaceutical ingredients (APIs):

1
UNII 021SEF3731 - ALBUTEROL SULFATE
 

Salbutamol is a selective β2-agonist providing short-acting (4-6 hour) bronchodilation with a fast onset (within 5 minutes) in reversible airways obstruction. At therapeutic doses it acts on the β2-adrenoceptors of bronchial muscle. Salbutamol is administered for the symptomatic relief of bronchospasm associated with chronic or acute asthma, bronchitis or other obstructive pulmonary diseases.

 
Read more about Salbutamol
2
UNII C137DTR5RG - THEOPHYLLINE
 

Theophylline is a bronchodilator. In addition it affects the function of a number of cells involved in the inflammatory processes associated with asthma and chronic obstructive airways disease. Theophylline stimulates the myocardium and produces a diminution of venous pressure in congestive heart failure leading to marked increase in cardiac output.

 
Read more about Theophylline

Packages

This drug has been approved in Nigeria as follows:

Identifier Form Presentation Description Approval
B4-1638 Tablet Tekanol Tablets TAB 2 mg; 100 mg 10 x 1 x 10's, 1 x 50's Tablet 157 RNW-PP-216950 TEKANOL TABLETS SALBUTAMOL 2MG AND THEOPHYLLINE 100MG TABLETS Each uncoated Tablets contains: Salbutamol sulphate BP Eq. to Salbutamol 2mg, Maize starch, Methyl hydroxy benzoate, Propyl hydroxy benzoate, Purified Talc, Sodium Laurylsulfate, Crospovidone, magnesium stearate, colloidal anhydrous silica B4-1638 Drugs Imported Products 10 x1x10, 1x50 Prescription Only Medicine (POM) 6/25/2021 TEKA PHARMACEUTICAL CO. LTD, NO 52 ZUNGERU ROAD KANO 7066430624 tekapharmaceuticalco@outlook.com SAPPHIRE LIFESCIENCES PVT. LTD., Plot No. 43, 44 & 45, Palghar Taluka Industrial Co-op Estate Ltd, Boisar Road, Palghar (W), Palghar-401404, India. , India 06/07/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
R03DB04 Theophylline and adrenergics R Respiratory system → R03 Drugs for obstructive airway diseases → R03D Other systemic drugs for obstructive airway diseases → R03DB Xanthines and adrenergics
Discover more medicines within R03DB04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
NG Registered Drug Product Database B4-1638

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.